In addition to mediating GC resistance in B-ALL, hypermorphic PLCγ2 mutations, which confer constitutive signaling have been shown to similarly induce drug resistance in chronic lymphocytic leukemia in which PLC signaling is important for survival and proliferation18,20,22,23. This evidence concerns the gene PLCG2 and B-cell chronic lymphocytic leukemia.